carboxyphosphamide has been researched along with Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heydrich, D; Hohorst, HJ; Voelcker, G; Wagner, T | 1 |
Boddy, AV; Cole, M; Idle, JR; Pearson, AD; Price, L; Tasso, MJ; Wyllie, R; Yule, SM | 1 |
De Bruijn, EA; Momerency, G; Slee, PH; Van Cauwenberghe, K; Van Oosterom, AT | 1 |
Coulter, CE; Hadidi, AH; Idle, JR | 1 |
4 other study(ies) available for carboxyphosphamide and Neoplasms
Article | Year |
---|---|
[Blood level and urinary excretion of activated cyclophosphamide and its deactivation products in man (author's transl)].
Topics: Aged; Animals; Biotransformation; Blood Proteins; Cyclophosphamide; Female; Humans; Kinetics; Male; Mice; Middle Aged; Neoplasms; Phosphoramide Mustards; Protein Binding; Rats; Species Specificity | 1980 |
Cyclophosphamide metabolism in children.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Chromatography, Thin Layer; Cyclophosphamide; Densitometry; Drug Stability; Female; Glucuronidase; Humans; Hydrogen-Ion Concentration; Individuality; Infant; Male; Neoplasms; Phosphoramide Mustards; Sulfatases | 1995 |
The determination of cyclophosphamide and its metabolites in blood plasma as stable trifluoroacetyl derivatives by electron capture chemical ionization gas chromatography/mass spectrometry.
Topics: Antineoplastic Agents; Cyclophosphamide; Gas Chromatography-Mass Spectrometry; Humans; Neoplasms; Nitrogen Mustard Compounds; Oxazoles; Oxazolidinones; Phosphoramide Mustards | 1994 |
Phenotypically deficient urinary elimination of carboxyphosphamide after cyclophosphamide administration to cancer patients.
Topics: Adult; Aged; Chromatography, Thin Layer; Cyclophosphamide; Female; Humans; Male; Middle Aged; Neoplasms; Phenotype; Phosphoramide Mustards | 1988 |